COLLEGIUM PHARMACEUTICAL, INC
COLL · XNASCIK 1267565fmd_10WRDHDSWWFQVWCJ6PE31B1H9NManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2 | 28 | 280 | 297 | 310 | 277 | 464 | 567 | 631 | 781 |
| Cost of revenue | 0 | 3 | 166 | 194 | 130 | 126 | 254 | 241 | 254 | 317 |
| Gross profit | 1 | 26 | 115 | 103 | 180 | 151 | 209 | 326 | 377 | 463 |
| Research and development | 15 | 9 | 9 | 10 | 10 | 9 | 4 | 0 | 0 | – |
| Selling, general and administrative | 81 | 93 | 127 | 116 | 114 | 119 | 172 | 159 | 210 | 285 |
| Total operating expenses | 96 | – | 135 | 127 | 124 | 133 | 176 | 159 | 207 | 284 |
| Operating income | (94) | (75) | (21) | (24) | 56 | 18 | 33 | 167 | 170 | 180 |
| Interest expense | 0 | – | 20 | 1 | 29 | 21 | 63 | 83 | 74 | 82 |
| Other non-operating income (expense) | (0) | 1 | – | – | – | – | – | – | – | – |
| Income before taxes | – | – | (39) | (23) | 28 | (3) | (29) | 76 | 99 | 93 |
| Income tax expense | – | – | – | 0 | 1 | (75) | (4) | 28 | 29 | 30 |
| Net income from continuing operations | – | – | – | (23) | 27 | 72 | (25) | 48 | 69 | 63 |
| Net income | (94) | (75) | (39) | (23) | 27 | 72 | (25) | 48 | 69 | 63 |